Patent Assignment
Reel/Frame 073691/0579
Security Interest
Recorded: 2026-02-04
Pages: 13
Assignor
MAZE THERAPEUTICS, INC.
Executed: 2026-02-04
Assignee
HERCULES CAPITAL, INC., AS AGENT
1 NORTH B STREET, SUITE 2000, SAN MATEO, CALIFORNIA, 94401
Covered Properties
(32)
APOL1 Inhibitors and Methods of Use
Application:
18/277,943 →
Publication:
US US20240316038A1
APOL1 Inhibitors and Methods of Use
Application:
19/218,105 →
Publication:
US US20250282781A1
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
18/485,224 →
Publication:
US US20240199546A1
APOL1 Inhibitors and Methods of Use
Application:
19/104,696 →
Publication:
US US20260055083A1
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
19/131,916 →
Publication:
US US20260184693A1
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
19/131,919 →
Publication:
US US20260183284A1
APOL1 Inhibitors and Methods of Use
Application:
19/500,859 →
Methods of Using APOL1 Inhibitors
Application:
19/487,938 →
APOL1 Inhibitors and Methods of Use
Application:
19/502,619 →
APOL1 Inhibitors and Methods of Use Thereof
Application:
19/500,877 →
APOL1 Inhibitors and Methods of Uses Thereof
Application:
19/178,525 →
Publication:
US US20250320196A1
APOL1 Inhibitors and Uses Thereof
Application:
63/783,774 →
APOL1 Inhibitors and Methods of Use Thereof
Application:
63/772,321 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/762,990 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/763,024 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/763,039 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/925,271 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/763,052 →
APOL1 Inhibitor Dosages and Methods of Use Thereof
Application:
63/754,438 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/763,054 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/763,058 →
Inhibitors of Solute Carrier Family 6A Member 19 (SLC6A19) and Methods of Use Thereof
Application:
63/763,065 →
Compositions and Methods for Treating Neurodegenerative Diseases
Application:
17/796,563 →
Publication:
US US20230287409A1
Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Application:
19/399,293 →
Publication:
US US20260193237A1
Cycloalkyl Carboxylic Acid Derivatives as Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Application:
19/111,736 →
Publication:
US US20260021085A1
N-(Benzhydryl)Cycloalkylcarboxamide Derivatives as Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Application:
19/111,738 →
Publication:
US US20260085034A1
Dimeric Compounds as Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Application:
19/111,739 →
Publication:
US US20260098025A1
Vectors Comprising Stuffer Polynucleotide Sequences
Application:
18/263,118 →
Publication:
US US20240093189A1
APOL1 Inhibitors and Methods of Use
APOL1 Inhibitors and Methods of Use
Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 11, 2022
From: MORGANS, DAVID JOHN, JR.; MELLEM, KEVIN; POWERS, HANNAH L.; LEE, PATRICK SANG TAE
To: MAZE THERAPEUTICS, INC.
Reel/Frame 059895/0125 →
Assignment of Assignor's Interest
Sep 16, 2024
From: GOOLD, CARLETON PROCTOR; CHEN, RONALD; JANKI, PETER; GREEN, ERIC
To: MAZE THERAPEUTICS, INC.
Reel/Frame 068601/0783 →
Assignment of Assignor's Interest
Sep 16, 2024
From: GOOLD, CARLETON PROCTOR; CHEN, RONALD; GREEN, ERIC; JANKI, PETER
To: MAZE THERAPEUTICS, INC.
Reel/Frame 068601/0735 →
Assignment of Assignor's Interest
Nov 7, 2024
From: PITZEN, JENNIFER; DE LA HIGUERA MACIAS, MAXIMILIANO; COOPER, NICOLE; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 069190/0802 →
Assignment of Assignor's Interest
Nov 19, 2024
From: GOOLD, CARLETON PROCTOR; GRAHAM, ROBERT R; JANKI, PETER; CHEN, RONALD
To: MAZE THERAPEUTICS, INC.
Reel/Frame 069331/0899 →
Assignment of Assignor's Interest
Feb 28, 2025
From: LEE, PATRICK SANG TAE; EWING, TODD JONATHAN AUGUST; REID, ADAM NEIL; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 070371/0609 →
Assignment of Assignor's Interest
Mar 10, 2025
From: LEE, PATRICK SANG TAE; EWING, TODD JONATHAN AUGUST; REID, ADAM NEIL; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 070458/0199 →
Assignment of Assignor's Interest
Apr 4, 2025
From: BRONNER, SARAH M.; ZHANG, BIRONG; TSE, WINSTON CHUNG MING; REID, ADAM NEIL
To: MAZE THERAPEUTICS, INC.
Reel/Frame 070745/0662 →
Assignment of Assignor's Interest
Aug 22, 2025
From: ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE; REID, ADAM NEIL
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0313 →
Assignment of Assignor's Interest
Aug 22, 2025
From: ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE; REID, ADAM NEIL
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0217 →
Assignment of Assignor's Interest
Aug 22, 2025
From: ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE; REID, ADAM NEIL
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0235 →
Assignment of Assignor's Interest
Aug 22, 2025
From: ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE; REID, ADAM NEIL
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0241 →
Assignment of Assignor's Interest
Aug 22, 2025
From: ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE; REID, ADAM NEIL
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0250 →
Assignment of Assignor's Interest
Aug 22, 2025
From: PITZEN, JENNIFER; ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0339 →
Assignment of Assignor's Interest
Aug 22, 2025
From: PITZEN, JENNIFER; ZIEBENHAUS, CHRIS; MELLEM, KEVIN; COOPER, NICOLE
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0322 →
Assignment of Assignor's Interest
Aug 22, 2025
From: LEE, PATRICK SANG TAE; EWING, TODD JONATHAN AUGUST; REID, ADAM NEIL; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072092/0203 →
Assignment of Assignor's Interest
Sep 10, 2025
From: LEE, PATRICK SANG TAE; EWING, TODD JONATHAN AUGUST; REID, ADAM NEIL; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072210/0305 →
Assignment of Assignor's Interest
Sep 10, 2025
From: LEE, PATRICK SANG TAE; EWING, TODD JONATHAN AUGUST; REID, ADAM NEIL; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 072210/0265 →
Assignment of Assignor's Interest
Jan 21, 2026
From: MELLEM, KEVIN; PITZEN, JENNIFER; COOPER, NICOLE; TZITZILONIS, CHRISTOS
To: MAZE THERAPEUTICS, INC.
Reel/Frame 073538/0179 →
Assignment of Assignor's Interest
Jan 21, 2026
From: SINZ, CHRISTOPHER JOSEPH; ZHANG, BIRONG; BRONNER, SARAH M.; MORGANS, DAVID JOHN, JR.
To: MAZE THERAPEUTICS, INC.
Reel/Frame 073538/0392 →
Assignment of Assignor's Interest
Jan 21, 2026
From: LEE, PATRICK SANG TAE; SINZ, CHRISTOPHER JOSEPH; ZHANG, BIRONG; BRONNER, SARAH M.
To: MAZE THERAPEUTICS, INC.
Reel/Frame 073538/0728 →
Assignment of Assignor's Interest
Jan 21, 2026
From: HOEK, MAARTEN; ASSIMON, VICTORIA ANNE
To: MAZE THERAPEUTICS, INC.
Reel/Frame 073538/0839 →
Assignment of Assignor's Interest
Jan 21, 2026
From: PITZEN, JENNIFER; DE LA HIGUERA MACIAS, MAXIMILIANO; COOPER, NICOLE; SINZ, CHRISTOPHER JOSEPH
To: MAZE THERAPEUTICS, INC.
Reel/Frame 074478/0396 →
Assignment of Assignor's Interest
Jan 22, 2026
From: LEE, PATRICK SANG TAE; SINZ, CHRISTOPHER JOSEPH; ZHANG, BIRONG; BRONNER, SARAH M.
To: MAZE THERAPEUTICS, INC.
Reel/Frame 073554/0217 →
Assignment of Assignor's Interest
Jan 22, 2026
From: BRONNER, SARAH M.; ZHANG, BIRONG
To: MAZE THERAPEUTICS, INC.
Reel/Frame 073554/0289 →